CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please ensure that you fully understand the risks involved. CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please ensure that you fully understand the risks involved.

A2 Milk shares climb to record high of $17.25

With a2 Milk now trading at all-time highs, investors look to be gearing up for the infant formula maker’s full-year results set to be released August 21.

The a2 Milk Co Ltd share price has continued to rise in recent months, with impeccable fundamentals and institutional interest likely contributing to the recent upward price action.

Shares in the infant formula maker reached all-time highs of A$17.25 per share during today's trading session, up 64% since January.

What’s behind a2 Milk’s meteoric rise?

The bullishness surrounding a2 Milk Co Ltd (ASX: A2M) is hardly surprising when you consider the company’s impressive fundamentals and the significant growth opportunities it's pursuing.

A2 Milk’s 1H2019 revenue increased 41% to A$613 million, its earnings per share (EPS) increased 53% to A$0.20 per share, and its market capitalisation now tops A$12 billion.

In saying that, the company’s revenue breakdown continues to be skewed heavily towards a2 Milk’s Australian operations.

As of 1H2019, the company’s revenue breakdown read as follows: Australia & New Zealand contributed 68.2%, China and other Asian countries contributed 28.1% and the UK and USA contributed just 3.7%.

While Australia is a2 Milk’s most mature market, bringing in A$418 million in revenue for the first-half of 2019, investors are likely most interested in the explosive growth the company has reported in its more underdeveloped markets.

Revenue from the company’s China label, for example, rose 83% in 1H2019. China remains the world’s largest infant formula market.

Ultimately, these stable and growing financial results underscore the fact that demand for a2 Milk’s products remain robust across the company’s varied geographic segments.

A global growth strategy in focus

Though earnings remain solid, the company has placed a particular focus on growing its market share in China, the UK and the US.

Indeed, as we previously reported: UBS is of the opinion that a2 Milk has the potential to gain as much as a 10% market share in China’s $25 billion infant formula market by 2025.

UBS’s prediction does not seem unreasonable when considering that a2 Milk currently commands 5.7% of China’s infant formula market, according to Kantar Infant Formula market tracking.

This, among other reasons, was likely a deciding factor behind UBS’s decision to build a 5% stake in the infant formula maker.

Looking forward

A2 Milk shows little signs of slowing down its expansion plans anytime soon.

In its lastest investor presentation, the company stressed that it is aggressively investing in China and the US in an attempt to boost brand awareness.

While the company flagged that this increased marketing spend would eat into margins, investors are unlikely to be overly concerned by this, given the potential long-term benefits of gaining deeper market penetration.

a2 Milk Co Ltd will announce its full-year results on August 21.

IGA, may distribute information/research produced by its respective foreign affiliates within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

The information/research herein is prepared by IG Asia Pte Ltd (IGA) and its foreign affiliated companies (collectively known as the IG Group) and is intended for general circulation only. It does not take into account the specific investment objectives, financial situation, or particular needs of any particular person. You should take into account your specific investment objectives, financial situation, and particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit.

No representation or warranty is given as to the accuracy or completeness of this information. Consequently, any person acting on it does so entirely at their own risk. Please see important Research Disclaimer.

Please also note that the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.

Explore the markets with our free course

Learn how shares work – and discover the wide range of markets you can trade on – with IG Academy's free ’introducing the financial markets’ course.

Put learning into action

Try out what you’ve learned in this shares strategy article risk-free in your demo account.

Ready to trade shares?

Put the lessons in this article to use in a live account – upgrading is quick and easy.

  • Trade on over 16,000 popular global stocks
  • Protect your capital with risk management tools
  • React to breaking news with out-of-hours trading on 70 key US stocks

Inspired to trade?

Put your new knowledge into practice. Log in to your account now.

Live prices on most popular markets

  • Forex
  • Shares
  • Indices

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 20 mins.

The Momentum Report

Get the week’s momentum report sent directly to your inbox every Monday for FREE. The Week Ahead gives you a full calendar of upcoming key events to monitor in the coming week, as well as commentary and insight from our expert analysts on the major indices to watch.

For more info on how we might use your data, see our privacy notice and access policy and privacy webpage.

You might be interested in…

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.